Junjie Liang

5PUBLICATIONS
22CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 03, 2026
PPARα activation overcomes fibroinflammatory liver microenvironment-associated anti-PD-1 resistance in hepatocellular carcinoma by mediating GSDME-dependent pyroptosis.

|Jan 20, 2026
The UFL1-AKT positive feedback loop promotes breast cancer progression by enhancing lipid synthesis.

Fei Meng, Yating Du, Junjie Liang

|May 06, 2025
Idarubicin versus Epirubicin in Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: An Open-label, Randomized, Phase IV Trial.

Haikuan Liu, Wenzhe Fan, Haiqing Li

|Apr 30, 2025
CDK4/6-mediated phosphorylation of DUB3 promotes YAP1 stability and hepatocellular carcinoma progression.

Lei Huang, Wenying Yuan, Xinying Li

|Mar 12, 2024
GINS1 promotes ZEB1-mediated epithelial-mesenchymal transition and tumor metastasis via β-catenin signaling in hepatocellular carcinoma.

Junjie Liang, Nan Yao, Bo Deng

Pageof 1

Frequent Collaborators

1 joint publications

Tongzheng Liu

1 joint publications

Yingjie Zhu

1 joint publications

Haikuan Liu

1 joint publications

Wenzhe Fan